19 As expected, IL-17A expression was also ABT-263 purchase largely dependent on Th17-polarizing conditions (i.e. treatment with both TGF-β and IL-6; Fig. 1a), although a small number of IL-17A+ cells was observed in the TGF-β-treated cultures (data not shown), and was enhanced by the addition of IL-23. G-1 treatment resulted in an increase in the percentage of IL-10+ cells within Th 17 cell-polarized cultures (Fig. 1b), including within cultures supplemented with IL-23 (Fig. 1c), which is known to be important in stabilizing the phenotype of Th17 populations.6 This G-1-mediated IL-10 expression was specific as no increase

in the prevalence IL-17A+ cells was observed in either of the Th17-polarizing conditions (Fig. 1b,c). In addition, G-1 treatment had no effect on IFN-γ expression in cultures stimulated with CD3/28 alone (Fig. 1d); however, few IFN-γ+ cells were detected in the other culture conditions tested (see Supplementary material, Fig. S1). To determine whether

the induction of IL-10+ cells translated into a specific increase https://www.selleckchem.com/products/Roscovitine.html in the secretion of IL-10 from G-1-treated cultures, naive T cells were collected and stimulated as above, in the presence of TGF-β and IL-6. After 4 days of differentiation, DMSO-treated and G-1-treated cells were collected, washed with medium to remove any cytokines released over the course of differentiation, and re-plated Tangeritin at 106 cells/ml. Cells were then re-stimulated with anti-CD3ε antibody for 24 hr, after which culture medium was analysed for the presence of newly secreted IL-6, IL-10, IL-17A, TNF-α and IFN-γ by Luminex multiplex assay. Cells differentiated in the presence of G-1 produced approximately threefold more IL-10 than control cultures (Fig. 2a), consistent with our observation that G-1 induced an IL-10-producing population. No difference in the secretion of IL-6, IL-17A, TNF-α or IFN-γ was detected (Fig. 2b–e), again suggesting that G-1 was specifically driving the production of the anti-inflammatory cytokine IL-10, and not pro-inflammatory mediators

such as TNF-α and IFN-γ. Taken together, these data show that G-1 can specifically drive IL-10 expression within, and secretion from, CD4+ T-cell populations. As G-1-induced IL-10 expression was dependent on Th17-polarizing conditions, we sought to determine the relationship between G-1-induced IL-10+ cells and those expressing the characteristic Th17 cytokine IL-17A. Hence, naive T cells were again collected by FACS and polyclonally stimulated in the presence of TGF-β and IL-6. Cells were cultured with increasing doses of G-1 (1–500 nm) and analysed for IL-17A and IL-10 by intracellular cytokine staining (Fig. 3a). Our data reveal a dose-dependent increase in IL-10+ IL-17A− (Fig. 3a,b) and IL-10+ IL-17A+ cells (Fig.